WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
New research labs and process development services to enable next generation therapeutics
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Developed in consultation with clinicians and patients for an enhanced user experience
Subscribe To Our Newsletter & Stay Updated